betaxolol has been researched along with Alzheimer Disease in 1 studies
Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babiloni, C | 1 |
| Squitti, R | 1 |
| Del Percio, C | 1 |
| Cassetta, E | 1 |
| Ventriglia, MC | 1 |
| Ferreri, F | 1 |
| Tombini, M | 1 |
| Frisoni, G | 1 |
| Binetti, G | 1 |
| Gurzi, M | 1 |
| Salinari, S | 1 |
| Zappasodi, F | 1 |
| Rossini, PM | 1 |
1 other study available for betaxolol and Alzheimer Disease
| Article | Year |
|---|---|
Free copper and resting temporal EEG rhythms correlate across healthy, mild cognitive impairment, and Alzheimer's disease subjects.
Topics: Aged; Alzheimer Disease; Analysis of Variance; Betaxolol; Brain Mapping; Ceruloplasmin; Cognition Di | 2007 |